The Food and Drug Administration’s approval of the cancer drug Blenrep late Thursday offered some vindication for GSK, which ...

FDA approves cancer drug belantamab mafodotin-blmf for relapsed multiple myeloma in combination with bortezomib and dexamethasone.

GSK's London-listed shares fell about 2% on Friday after the U.S. Food and Drug Administration approved only one of two ...

The antibody-drug conjugate, withdrawn from the market by GSK in 2022 after failing a confirmatory study, was approved ...

Three years after its global market withdrawal and months after a negative advisory committee vote, GSK can officially call it a comeback for its multiple myeloma drug Blenrep in the U.S., albeit w | ...

Overall, 46% of the respondents correctly identified chronic cough. Of these, allergists/immunologists had the highest ...

The New York-listed healthcare giant is keen to recoup the £1.2bn it paid to buy the supplier of the electronic patient ...

The FTSE 100 Index rose for four consecutive days and reached its all-time high of £9,578 as traders reacted to key earnings ...

A recent study shows adults with cardiovascular disease (CVD) have a higher risk of developing shingles. People who have two ...

An announcement from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has announced the purchase of 248,000 of its own ordinary shares as part ...

A pharmaceutical factory which ceased production earlier this year has been bought by Britain's biggest defence firm. BAE ...